EquityEquity - OtherVery High Risk
Regular
NAV (18-Sep-25)
Returns (Since Inception)
Fund Size
₹382 Cr
Expense Ratio
2.45%
ISIN
INF204KC1FO4
Minimum SIP
₹100
Exit Load
1.00%
Inception Date
22 Jul 2025
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
Since Inception
+7.56%
— (Cat Avg.)
Equity | ₹353.98 Cr | 92.76% |
Others | ₹27.63 Cr | 7.24% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Nestle India Ltd | Equity | ₹32.37 Cr | 8.48% |
Hindustan Unilever Ltd | Equity | ₹27.93 Cr | 7.32% |
Triparty Repo | Cash - Repurchase Agreement | ₹27.36 Cr | 7.17% |
Britannia Industries Ltd | Equity | ₹26.21 Cr | 6.87% |
Maruti Suzuki India Ltd | Equity | ₹24.81 Cr | 6.50% |
Cummins India Ltd | Equity | ₹24.14 Cr | 6.32% |
Hyundai Motor India Ltd | Equity | ₹20.91 Cr | 5.48% |
Vedanta Ltd | Equity | ₹17.88 Cr | 4.68% |
Samvardhana Motherson International Ltd | Equity | ₹16.7 Cr | 4.37% |
Fortis Healthcare Ltd | Equity | ₹15.95 Cr | 4.18% |
LTIMindtree Ltd | Equity | ₹15.4 Cr | 4.04% |
Dr Reddy's Laboratories Ltd | Equity | ₹11.34 Cr | 2.97% |
Sai Life Sciences Ltd | Equity | ₹10.31 Cr | 2.70% |
Gujarat Fluorochemicals Ltd Ordinary Shares | Equity | ₹10.08 Cr | 2.64% |
Schaeffler India Ltd | Equity | ₹9.87 Cr | 2.59% |
Lupin Ltd | Equity | ₹9.47 Cr | 2.48% |
United Breweries Ltd | Equity | ₹9.28 Cr | 2.43% |
United Spirits Ltd | Equity | ₹9.18 Cr | 2.40% |
Siemens Energy India Ltd | Equity | ₹8.44 Cr | 2.21% |
TBO Tek Ltd | Equity | ₹8.37 Cr | 2.19% |
Infosys Ltd | Equity | ₹7.35 Cr | 1.93% |
Kaynes Technology India Ltd | Equity | ₹6.74 Cr | 1.76% |
Escorts Kubota Ltd | Equity | ₹5.02 Cr | 1.32% |
Colgate-Palmolive (India) Ltd | Equity | ₹4.43 Cr | 1.16% |
Divi's Laboratories Ltd | Equity | ₹4.29 Cr | 1.12% |
eClerx Services Ltd | Equity | ₹4.22 Cr | 1.11% |
3M India Ltd | Equity | ₹3.82 Cr | 1.00% |
Bharat Forge Ltd | Equity | ₹3.63 Cr | 0.95% |
Syngene International Ltd | Equity | ₹3.13 Cr | 0.82% |
Gokaldas Exports Ltd | Equity | ₹2.69 Cr | 0.71% |
Net Current Assets | Cash | ₹0.22 Cr | 0.06% |
Cash Margin - Ccil | Cash - Collateral | ₹0.05 Cr | 0.01% |
Sanofi Consumer Healthcare India Ltd | Equity | ₹0.03 Cr | 0.01% |
Large Cap Stocks
60.87%
Mid Cap Stocks
24.36%
Small Cap Stocks
7.53%
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Consumer Defensive | ₹109.4 Cr | 28.67% |
Consumer Cyclical | ₹86.98 Cr | 22.79% |
Healthcare | ₹54.52 Cr | 14.29% |
Industrials | ₹39.71 Cr | 10.41% |
Basic Materials | ₹27.96 Cr | 7.33% |
Technology | ₹26.97 Cr | 7.07% |
Utilities | ₹8.44 Cr | 2.21% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since July 2025
Since July 2025
ISIN INF204KC1FO4 | Expense Ratio 2.45% | Exit Load 1.00% | Fund Size ₹382 Cr | Age 1 month | Lumpsum Minimum ₹500 | Fund Status Open Ended Investment Company | Benchmark Nifty MNC TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Total AUM
₹6,53,524 Cr
Address
4th Floor, Tower A, Peninsula Business Park, Mumbai, 400 013
Your principal amount will be at Very High Risk
EquityEquity - OtherVery High Risk
Regular
NAV (18-Sep-25)
Returns (Since Inception)
Fund Size
₹382 Cr
Expense Ratio
2.45%
ISIN
INF204KC1FO4
Minimum SIP
₹100
Exit Load
1.00%
Inception Date
22 Jul 2025
Your principal amount will be at Very High Risk
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
Since Inception
+7.56%
— (Cat Avg.)
Equity | ₹353.98 Cr | 92.76% |
Others | ₹27.63 Cr | 7.24% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Nestle India Ltd | Equity | ₹32.37 Cr | 8.48% |
Hindustan Unilever Ltd | Equity | ₹27.93 Cr | 7.32% |
Triparty Repo | Cash - Repurchase Agreement | ₹27.36 Cr | 7.17% |
Britannia Industries Ltd | Equity | ₹26.21 Cr | 6.87% |
Maruti Suzuki India Ltd | Equity | ₹24.81 Cr | 6.50% |
Cummins India Ltd | Equity | ₹24.14 Cr | 6.32% |
Hyundai Motor India Ltd | Equity | ₹20.91 Cr | 5.48% |
Vedanta Ltd | Equity | ₹17.88 Cr | 4.68% |
Samvardhana Motherson International Ltd | Equity | ₹16.7 Cr | 4.37% |
Fortis Healthcare Ltd | Equity | ₹15.95 Cr | 4.18% |
LTIMindtree Ltd | Equity | ₹15.4 Cr | 4.04% |
Dr Reddy's Laboratories Ltd | Equity | ₹11.34 Cr | 2.97% |
Sai Life Sciences Ltd | Equity | ₹10.31 Cr | 2.70% |
Gujarat Fluorochemicals Ltd Ordinary Shares | Equity | ₹10.08 Cr | 2.64% |
Schaeffler India Ltd | Equity | ₹9.87 Cr | 2.59% |
Lupin Ltd | Equity | ₹9.47 Cr | 2.48% |
United Breweries Ltd | Equity | ₹9.28 Cr | 2.43% |
United Spirits Ltd | Equity | ₹9.18 Cr | 2.40% |
Siemens Energy India Ltd | Equity | ₹8.44 Cr | 2.21% |
TBO Tek Ltd | Equity | ₹8.37 Cr | 2.19% |
Infosys Ltd | Equity | ₹7.35 Cr | 1.93% |
Kaynes Technology India Ltd | Equity | ₹6.74 Cr | 1.76% |
Escorts Kubota Ltd | Equity | ₹5.02 Cr | 1.32% |
Colgate-Palmolive (India) Ltd | Equity | ₹4.43 Cr | 1.16% |
Divi's Laboratories Ltd | Equity | ₹4.29 Cr | 1.12% |
eClerx Services Ltd | Equity | ₹4.22 Cr | 1.11% |
3M India Ltd | Equity | ₹3.82 Cr | 1.00% |
Bharat Forge Ltd | Equity | ₹3.63 Cr | 0.95% |
Syngene International Ltd | Equity | ₹3.13 Cr | 0.82% |
Gokaldas Exports Ltd | Equity | ₹2.69 Cr | 0.71% |
Net Current Assets | Cash | ₹0.22 Cr | 0.06% |
Cash Margin - Ccil | Cash - Collateral | ₹0.05 Cr | 0.01% |
Sanofi Consumer Healthcare India Ltd | Equity | ₹0.03 Cr | 0.01% |
Large Cap Stocks
60.87%
Mid Cap Stocks
24.36%
Small Cap Stocks
7.53%
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Consumer Defensive | ₹109.4 Cr | 28.67% |
Consumer Cyclical | ₹86.98 Cr | 22.79% |
Healthcare | ₹54.52 Cr | 14.29% |
Industrials | ₹39.71 Cr | 10.41% |
Basic Materials | ₹27.96 Cr | 7.33% |
Technology | ₹26.97 Cr | 7.07% |
Utilities | ₹8.44 Cr | 2.21% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since July 2025
Since July 2025
ISIN INF204KC1FO4 | Expense Ratio 2.45% | Exit Load 1.00% | Fund Size ₹382 Cr | Age 1 month | Lumpsum Minimum ₹500 | Fund Status Open Ended Investment Company | Benchmark Nifty MNC TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Total AUM
₹6,53,524 Cr
Address
4th Floor, Tower A, Peninsula Business Park, Mumbai, 400 013
Get your portfolio reviewed by experts
Download Wealth Monitor App
Track and monitor all
your investments